Literature DB >> 9575817

Measurement of dermal collagen synthesis rate in vivo in humans.

W A el-Harake1, M A Furman, B Cook, K S Nair, J Kukowski, I G Brodsky.   

Abstract

Accumulation of collagen produces organ dysfunction in many pathological conditions. We measured the fractional synthesis rate (FSR) of dermal collagen in five human volunteers from the increment of [13C]proline in detergent-soluble dermal collagen hydroxylated to hydroxyproline during a continuous infusion of L-[1-13C]proline. In these and eight other volunteers, we measured [13C]proline enrichment in skin aminoacyl-tRNA, skin tissue fluid amino acid, and plasma. The prolyl-[13C]tRNA enrichment was one-half that in tissue fluid proline and more than threefold less than in plasma. The FSR of dermal collagen was 0.076 +/- 0.063%/h (mean +/- SD), similar to previously reported rates for skeletal muscle contractile proteins and substantially slower than hepatically derived circulating proteins such as albumin or fibrinogen. We conclude that the FSR of human dermal collagen resembles that of other human proteins considered to display slow turnover. The current method for its measurement may be used to determine the regulation of collagen synthesis in other organs and disease states.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575817     DOI: 10.1152/ajpendo.1998.274.4.E586

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  A weak link in metabolism: the metabolic capacity for glycine biosynthesis does not satisfy the need for collagen synthesis.

Authors:  Enrique Meléndez-Hevia; Patricia De Paz-Lugo; Athel Cornish-Bowden; María Luz Cárdenas
Journal:  J Biosci       Date:  2009-12       Impact factor: 1.826

2.  Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover.

Authors:  E Gineyts; P A Cloos; O Borel; L Grimaud; P D Delmas; P Garnero
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 3.  RNA protein interactions governing expression of the most abundant protein in human body, type I collagen.

Authors:  Branko Stefanovic
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-05-28       Impact factor: 9.957

4.  Characterization of Sequence-Specific Binding of LARP6 to the 5' Stem-Loop of Type I Collagen mRNAs and Implications for Rational Design of Antifibrotic Drugs.

Authors:  Lela Stefanovic; Blaine H Gordon; Robert Silvers; Branko Stefanovic
Journal:  J Mol Biol       Date:  2021-12-08       Impact factor: 5.469

5.  Discovery of a Lead Compound for Specific Inhibition of Type I Collagen Production in Fibrosis.

Authors:  Branko Stefanovic; Heather A Michaels; Adel Nefzi
Journal:  ACS Med Chem Lett       Date:  2021-02-24       Impact factor: 4.345

6.  Using stable isotope analysis to understand the migration and trophic ecology of northeastern Pacific white sharks (Carcharodon carcharias).

Authors:  Aaron B Carlisle; Sora L Kim; Brice X Semmens; Daniel J Madigan; Salvador J Jorgensen; Christopher R Perle; Scot D Anderson; Taylor K Chapple; Paul E Kanive; Barbara A Block
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

7.  Role of LARP6 and nonmuscle myosin in partitioning of collagen mRNAs to the ER membrane.

Authors:  Hao Wang; Branko Stefanovic
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

8.  Discovery and evaluation of inhibitor of LARP6 as specific antifibrotic compound.

Authors:  Branko Stefanovic; Zarko Manojlovic; Cynthia Vied; Crystal-Dawn Badger; Lela Stefanovic
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

9.  Imaging of type I procollagen biosynthesis in cells reveals biogenesis in highly organized bodies; Collagenosomes.

Authors:  Branko Stefanovic; Lela Stefanovic; Zarko Manojlovic
Journal:  Matrix Biol Plus       Date:  2021-06-23

10.  Akt mediated phosphorylation of LARP6; critical step in biosynthesis of type I collagen.

Authors:  Yujie Zhang; Branko Stefanovic
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.